期刊文献+

急性冠状动脉综合征患者炎症相关分子水平变化的临床意义 被引量:5

Clinical Significance of Inflammation-related Molecular Level Changes in Acute Coronary Syndrome
下载PDF
导出
摘要 目的观察在不同类型冠心病(CHD)患者血清中,白介素-6(IL-6)、IL-18、C反应蛋白(CRP)、基质金属蛋白酶-2(MMP-2)、单核细胞趋化蛋白-1(MCP-1)等分子水平及血脂变化,探讨其在急性冠状动脉综合征(ACS)发病中的作用及其与冠状动脉病变程度的相关性及诊断意义。方法急性心肌梗死(AMI)组31例、不稳定型心绞痛(UAP)组32例、稳定型心绞痛(SAP)组35例,另选取同期30例正常健康者为对照组。酶联免疫吸附法(ELISA)测定血清IL-6、IL-18、MMP-2、MCP-1和CRP的浓度;速率散射法测血清CRP水平;血脂及脂蛋白含量测定分别用酶化学法与直接测定法检测。结果急性冠脉综合征患者(ACS)IL-6、IL-18和CRP水平,均显著高于对照组(P<0.05,P<0.01)和SAP组患者(P<0.05,P<0.01)。随着病情的加重,IL-6、IL-18、MMP-2和MCP-1水平均表现出进行性升高的趋势。患者血清IL-6、IL-18与CRP水平显著相关;患者血清IL-6与IL-18水平亦呈正相关。结论 ACS实际上是炎症、免疫、脂质代谢紊乱等多种因素综合作用的结果,所以对ACS的诊断,应综合炎症、脂类代谢等多种因素,进行评价各检测指标的诊断意义;IL-6、IL-18与CRP,可作为ACS发病和冠脉病变不稳定严重程度的预测因子。 Objective To observe the changes of serum IL-6,IL-18,C-reactive protein(CRP),matrix metalloproteinase-2(MMP-2),monocyte chemoattractant protein-1(MCP-1) and blood lipid in different types of coronary heart disease(CHD) patients.To explore the acute coronary syndrome(ACS) and its role in the pathogenesis of coronary artery lesions with the degree of relevance and diagnostic significance.Methods Acute myocardial infarction(AMI) group 31 cases,unstable angina pectoris(UAP) group 32 cases,unstable angina pectoris(SAP) group 35 cases,and the other select the same period 30 cases of normal control group.Enzyme-linked immunosorbent assay(ELISA) for determination of serum IL-6,IL-18,MMP-2,MCP-1 and CRP concentrations;scattering rate measured serum CRP levels;determination of blood lipid and lipoprotein enzyme chemical method used separately with Direct determination method.Results The patients with ACS IL-6,IL-18 and CRP were significantly higher(P〈0.05,P〈0.01) and SAP patients(P〈0.05,P〈0.01).As the disease increase,IL-6,IL-18,MMP-2 and MCP-1 showed the water to increase the average trend.Serum IL-6,IL-18 and CRP levels significantly correlated;serum IL-6 and IL-18 level was also positively correlated.Conclusion ACS are the results of the complex actions by inflammation,immunity,lipid metabolism disorders and many other factors.The diagnosis of ACS should be general inflammation,lipid metabolism,such as a variety of factors,a comprehensive evaluation of the diagnostic significance of detection of targets;IL-6,IL-18,and CRP can be used as ACS and unstable coronary artery disease incidence and severity of the prediction factor.
出处 《黑龙江医学》 2010年第6期401-404,共4页 Heilongjiang Medical Journal
关键词 炎症因子 C反应蛋白 急性冠状动脉综合征 冠状动脉疾病 冠状动脉造影 Acute coronary syndrome Inflammatory cytokines C-reactive protein Coronary artery disease Coronary angiography
  • 相关文献

参考文献10

  • 1Novo G,Assennato P,Caruso M,et al.Clinical significance of macrophage colony stimulating factor levels in acute coronary syndrome[J].Minerva Cardioangiol,2009,57(1):7-11.
  • 2Ndrepepa G,Braun S,Iijima R,et al.Total leucocyte count,but not C-reactive protein,predicts 1-year mortality in patients with acute coronary syndromes treated with percutaneous coronary intervention[J].Clin Sci (Lond),2009,116(8):651-658.
  • 3唐小龙,江振友,蔡淑玉,董军,肖瑞,卢燕茹.IL-6下调血管内皮细胞组织因子抑制物表达[J].第二军医大学学报,2005,26(2):147-150. 被引量:6
  • 4Senturk T,Sarandol E,Gullulu S,et al.Serum arylesterase activity is negatively correlated with inflammatory markers in patients with acute coronary syndromes[J].Saudi Med J,2009,30(3):334-339.
  • 5Takano M,Mizuno K,Okamatsu K,et al.Mechanical and structural characteristic of vulnerable plaques:analysis by coronary angioscopy and intravascular ultrasound[J].J Am Coll Cardiol,2001,38(1):99-104.
  • 6Woods A,Brull D J,Humphries S E,et al.Genetics of inflammation and risk of coronary artery disease:the central role of interleukin-6[J].Eur Heart J,2000,21 (19):1 574-1 583.
  • 7唐小龙,江振友,董军,刘小澄,蔡淑玉,肖瑞,卢燕茹.IL-6对血管内皮细胞活性及TFmRNA表达的影响[J].四川大学学报(医学版),2006,37(2):234-237. 被引量:5
  • 8Narain V S,Gupta N,Sethi R,et al.Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome[J].Indian Heart J,2008,60(6):536-542.
  • 9徐晓东,刘建平,刘珉.低密度脂蛋白胆固醇/高密度脂蛋白胆固醇、甘油三酯/高密度脂蛋白胆固醇和尿酸与冠心病的关系[J].临床心电学杂志,2004,13(2):121-122. 被引量:6
  • 10柳淑云,孙炎晨,林涛,白荣杰.C-反应蛋白检测在急性冠脉综合征中的诊断价值[J].黑龙江医学,2005,29(7):529-529. 被引量:1

二级参考文献30

  • 1陈忠,马根山,黄峻,朱铁兵,杨志健,王连生,曹克将.早发冠心病患者血浆C反应蛋白与临床表型及冠状动脉病变的关系[J].中国临床康复,2004,8(36):8195-8197. 被引量:5
  • 2Sorrentio mJ Cholesterol reduction to prevent CAD:What do the data show? Post Graduate Med,2000,108:40-56
  • 3Cleeman Jl Executive summary of the third report of the national cholesterol education program(NCEP)expert panel on detection,evaluation,and treatment of high blood Cholesterol in adults(adults treatment panel Ⅲ).JAMA,2001,285:2486-2497
  • 4Coughlam BJ,Sorrentio MI.Dose hypertriglyceridemia increase the risk of CAD?Post Graduate Med,2001,108:77-84
  • 5Bickel C,Rupprecht HJ,Blankenberg S,etal.Serum uric aeid as an independent predictor of mortality in patients with angiorgaphically proven coronary artery disease.Am J Cardiol,2002,89:12-17
  • 6Lamendola C.Hypertriglyceridemia and low high-density lipoprotein cholesterol for coronary artery disease?Cardiovasc Nurs,2001,14:79-90
  • 7Chen YC,Wang SY.Activation of terminally differentiated human monocytes/macrophages by dengue virus: productive infection,hierarchical production of innate cytokines and chemokines,and the synergistic effect of lipopolysaccharide[J].J Virol,2002,76(19):9877-9887.
  • 8Mulligan-Kehoe MJ,Kleimman HK,Drinane M,et al.A truncated plasminogen activator inhibitor-1 protein blocks the availability of heparin-binding vascular endothelial growth factor A isoforms[J].J Biol Chem,2002,277(50): 49077-49089.
  • 9Gando S,Kameue T,Matsuda N,et al. Imbalances between the levels of tissue factor and tissue factor pathway inhibitor in ARDS patients[J].Thrombosis Res,2003,109(2-3): 119-124.
  • 10Soda K,Kano Y,Kawakami M,et al. Excessive increase of serum interleukin 6 jeopardizes host defense against multi-bacterial infection[J].Cytokine,2003,21(6): 295-302.

共引文献14

同被引文献43

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部